Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
Georg
G
Stary
Norbert
N
Kohrgruber
Andreas M
AM
Herneth
Alexander
A
Gaiger
Georg
G
Stingl
Armin
A
Rieger
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005871:Castleman Disease / Q000150:complications / Q000188:drug therapy*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013792:Thalidomide / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069283:Rituximab; D013792:Thalidomide